Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Matsuda, S. Lolait, M. Brownstein, A. Young, T. Bonner (1990)
Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 346
W. Knowles (1992)
Normal anatomy and neurophysiology of the hippocampal formation.Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society, 9 2
P. Faris, B. Komisaruk, L. Watkins, D. Mayer (1983)
Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia.Science, 219 4582
M. Glass, C. Felder (1997)
Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Augments cAMP Accumulation in Striatal Neurons: Evidence for a Gs Linkage to the CB1 ReceptorThe Journal of Neuroscience, 17
S. Bachus, Thomas Hyde, Mary Herman, M. Egan, J. Kleinman (1997)
Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics.Journal of psychiatric research, 31 2
S. Gabriel, M. Davidson, V. Haroutunian, P. Powchik, L. Bierer, D. Purohit, D. Perl, K. Davis (1996)
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortexBiological Psychiatry, 39
I. Katona, B. Sperlágh, A. Sik, Attila Käfalvi, E. Vizi, K. Mackie, T. Freund (1999)
Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal InterneuronsThe Journal of Neuroscience, 19
H. Emrich, F. Leweke, U. Schneider (1997)
Towards a Cannabinoid Hypothesis of Schizophrenia: Cognitive Impairments Due to Dysregulation of the Endogenous Cannabinoid SystemPharmacology Biochemistry and Behavior, 56
P. Mailleux, J. Vanderhaeghen (1992)
Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistryNeuroscience, 48
W. Devane, L. Hanuš, A. Breuer, R. Pertwee, L. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, R. Mechoulam (1992)
Isolation and structure of a brain constituent that binds to the cannabinoid receptor.Science, 258 5090
Knowles Wd (1992)
Normal anatomy and neurophysiology of the hippocampal formation.Journal of Clinical Neurophysiology, 9
K. Tsou, S. Brown, Sañudo-Peña Mc, K. Mackie, J. Walker (1998)
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous systemNeuroscience, 83
M. Herkenham, A. Lynn, Little, J. Mr, L. Melvin, deCosta Br, K. Rice (1990)
Cannabinoid receptor localization in brain.Proceedings of the National Academy of Sciences of the United States of America, 87 5
T. Freund, G. Buzsáki (1998)
Interneurons of the hippocampusHippocampus, 6
J. Crawley, R. Corwin (1994)
Biological actions of cholecystokininPeptides, 15
K. Mackie, B. Hille (1992)
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.Proceedings of the National Academy of Sciences of the United States of America, 89
Gaynor Paton, R. Pertwee, S. Davies (1998)
Correlation between cannabinoid mediated effects on paired pulse depression and induction of long term potentiation in the rat hippocampal sliceNeuropharmacology, 37
M. Shen, T. Piser, V. Seybold, S. Thayer (1996)
Cannabinoid Receptor Agonists Inhibit Glutamatergic Synaptic Transmission in Rat Hippocampal CulturesThe Journal of Neuroscience, 16
J. Crawley (1991)
Cholecystokinin-dopamine intearctionsTrends in Pharmacological Sciences, 12
K. Fredens, K. Stengaard-Pedersen, L. Larsson (1984)
Localization of enkephalin and cholecystokinin immunoreactivities in the perforant path terminal fields of the rat hippocampal formationBrain Research, 304
A. Zimmer, A. Zimmer, A. Hohmann, M. Herkenham, T. Bonner (1999)
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.Proceedings of the National Academy of Sciences of the United States of America, 96 10
D. Piomelli, M. Beltramo, A. Giuffrida, N. Stella (1998)
Endogenous Cannabinoid SignalingNeurobiology of Disease, 5
M. Beinfeld (1996)
Cholecystokinin (CCK) release from rat brain slices in vitro is enhanced by agents which elevate intracellular cAMPRegulatory Peptides, 67
R. Reidelberger (1994)
Cholecystokinin and control of food intake.The Journal of nutrition, 124 8 Suppl
K. Tóth, T. Freund (1992)
Calbindin D28k-containing nonpyramidal cells in the rat hippocampus: Their immunoreactivity for GABA and projection to the medial septumNeuroscience, 49
V. Marzo, D. Melck, T. Bisogno, L. Petrocellis (1998)
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory actionTrends in Neurosciences, 21
F. Silva, M. Witter, P. Boeijinga, A. Lohman (1990)
Anatomic organization and physiology of the limbic cortex.Physiological reviews, 70 2
R. Greenwood, Steve Godar, T. Reaves, J. Hayward (1981)
Cholecystokinin in hippocampal pathwaysJournal of Comparative Neurology, 203
Terranova Terranova, Michaud Michaud, Le Fur Le Fur, Soubrié Soubrié (1995)
Inhibition of long‐term potentiation in rat hippocampal slices by anandamide and WIN55212–2: reversal by SR141716A, a selective antagonist of CB1 cannabinoid receptorsNaunyn Schmiedebergs Arch. Pharmacol., 352
H. Fink, A. Rex, M. Voits, J. Voigt (1998)
Major biological actions of CCK – a critical evaluation of research findingsExperimental Brain Research, 123
J. Crawley (1991)
Cholecystokinin-dopamine interactions.Trends in pharmacological sciences, 12 6
A. Giuffrida, L. Parsons, T. Kerr, F. Fonseca, M. Navarro, D. Piomelli (1999)
Dopamine activation of endogenous cannabinoid signaling in dorsal striatumNature Neuroscience, 2
C. Felder, K. Joyce, E. Briley, J. Mansouri, K. Mackie, O. Blond, Y. Lai, A. Ma, R. Mitchell (1995)
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.Molecular pharmacology, 48 3
Udo Schneider, F. Leweke, K. Mueller‐Vahl, Hinderk Emrich (1998)
Cannabinoid/anandamide system and schizophrenia: is there evidence for association?Pharmacopsychiatry, 31 Suppl 2
E. Schlicker, J. Timm, J. Zentner, M. Göthert (1997)
Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampusNaunyn-Schmiedeberg's Archives of Pharmacology, 356
K. Mackie, Y. Lai, R. Westenbroek, R. Mitchell (1995)
Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor, 15
M. Raiteri, P. Paudice, F. Vallebuona (1993)
Release of cholecystokinin in the central nervous systemNeurochemistry International, 22
P. Morino, M. Herrera-Marschitz, M. Castel, U. Ungerstedt, A. Varró, G. Dockray, T. Hökfelt (1994)
Cholecystokinin in Cortico‐striatal Neurons in the Rat: Immunohistochemical Studies at the Light and Electron Microscopical LevelEuropean Journal of Neuroscience, 6
A. Duggan (1992)
Neuropharmacology of pain.Current opinion in neurology and neurosurgery, 5 4
A. Björklund, T. Hökfelt, M. Kuhar (1984)
Classical transmitters and transmitter receptors in the CNS
V. Marzo, D. Deutsch (1998)
Biochemistry of the Endogenous Ligands of Cannabinoid ReceptorsNeurobiology of Disease, 5
E. Soriano, R. Nitsch, M. Frotscher (1990)
Axo‐axonic chandelier cells in the rat fascia dentata: Golgi‐electron microscopy and immunocytochemical studiesJournal of Comparative Neurology, 293
B. Martin, A. Lichtman (1998)
Cannabinoid Transmission and Pain PerceptionNeurobiology of Disease, 5
R. Mattes, K. Engelman, L. Shaw, M. Elsohly (1994)
Cannabinoids and appetite stimulationPharmacology Biochemistry and Behavior, 49
C. Castellano, S. Cabib, A. Palmisano, V. Marzo, S. Puglisi-Allegra (1997)
The effects of anandamide on memory consolidation in mice involve both D1and D2 dopamine receptorsBehavioural Pharmacology, 8
A. Gulyás, N. Hájos, T. Freund (1996)
Interneurons Containing Calretinin Are Specialized to Control Other Interneurons in the Rat HippocampusThe Journal of Neuroscience, 16
L. Matsuda, T. Bonner, S. Lolait (1993)
Localization of cannabinoid receptor mRNA in rat brainJournal of Comparative Neurology, 327
Allyn Howlett (1995)
Pharmacology of cannabinoid receptors.Annual review of pharmacology and toxicology, 35
W. Suzuki (1996)
The anatomy, physiology and functions of the perirhinal cortexCurrent Opinion in Neurobiology, 6
M. Rhee, M. Bayewitch, T. Avidor-Reiss, Rivka Levy, Z. Vogel (1998)
Cannabinoid Receptor Activation Differentially Regulates the Various Adenylyl Cyclase IsozymesJournal of Neurochemistry, 71
C. Ledent, O. Valverde, G. Cossu, F. Petitet, J. Aubert, F. Beslot, G. Böhme, A. Imperato, T. Pedrazzini, B. Roques, G. Vassart, W. Fratta, M. Parmentier (1999)
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.Science, 283 5400
G. Tanda, F. Pontieri, G. Chiara (1997)
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.Science, 276 5321
D. Kellstein, D. Mayer (1991)
Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerancePain, 47
Susan Ingram, R. Krause, F. Baldino, L. Skeen, M. Lewis (1989)
Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization histochemistryJournal of Comparative Neurology, 287
L. Miller, R. Lai, D. Munoz (1998)
Contributions of the entorhinal cortex, amygdala and hippocampus to human memoryNeuropsychologia, 36
D. Pettit, Matthew Harrison, J. Olson, R. Spencer, G. Cabral (1998)
Immunohistochemical localization of the neural cannabinoid receptor in rat brainJournal of Neuroscience Research, 51
A. Gifford, C. Ashby (1996)
Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A.The Journal of pharmacology and experimental therapeutics, 277 3
A. Gulyás, K. Tóth, P. Danos, P. Danos, T. Freund, T. Freund (1991)
Subpopulations of GABAergic neurons containing parvalbumin, calbindin D28k, and cholecystokinin in the rat hippocampusJournal of Comparative Neurology, 312
V. Senatorov, V. Trudeau, B. Hu (1997)
Expression of cholecystokinin messenger RNA in reciprocally-connected auditory thalamus and cortex in the ratNeuroscience, 79
N. Stella, P. Schweitzer, D. Piomelli (1997)
A second endogenous cannabinoid that modulates long-term potentiationNature, 388
G. Roberts, P. Woodhams, J. Polak, T. Crow (1984)
Distribution of neuropeptides in the limbic system of the rat: The hippocampusNeuroscience, 11
A. Gulyás, T. Freund (1996)
Pyramidal cell dendrites are the primary targets of calbindin D28k‐immunoreactive interneurons in the hippocampusHippocampus, 6
J. Burgunder, W. Young (1988)
The distribution of thalamic projection neurons containing cholecystokinin messenger RNA, using in situ hybridization histochemistry and retrograde labeling.Brain research, 464 3
Sam Deadwyler, R. Hampson, B. Bennett, Thomas Edwards, J. Mu, M. Pacheco, Susan Ward, Steven Childers (1993)
Cannabinoids modulate potassium current in cultured hippocampal neurons.Receptors & channels, 1 2
C. Breivogel, S. Childers (1998)
The Functional Neuroanatomy of Brain Cannabinoid ReceptorsNeurobiology of Disease, 5
H. Steiner, T. Bonner, A. Zimmer, S. Kitai, A. Zimmer (1999)
Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice.Proceedings of the National Academy of Sciences of the United States of America, 96 10
M. Celio (1990)
Calbindin D-28k and parvalbumin in the rat nervous systemNeuroscience, 35
Cannabinoids can modulate motor behaviour, learning and memory, cognition and pain perception. These effects correlate with the expression of the cannabinoid receptor 1 (CB1) and with the presence of endogenous cannabinoids in the brain. In trying to obtain further insights into the mechanisms underlying the modulatory effects of cannabinoids, CB1‐positive neurons were determined in the murine forebrain at a single cell resolution. We performed a double in situ hybridization study to detect mRNA of CB1 in combination with mRNA of glutamic acid decarboxylase 65k, neuropeptide cholecystokinin (CCK), parvalbumin, calretinin and calbindin D28k, respectively. Our results revealed that CB1‐expressing cells can be divided into distinct neuronal subpopulations. There is a clear distinction between neurons containing CB1 mRNA either at high levels or low levels. The majority of high CB1‐expressing cells are GABAergic (γ‐aminobutyric acid) neurons belonging mainly to the cholecystokinin‐positive and parvalbumin‐negative type of interneurons (basket cells) and, to a lower extent, to the calbindin D28k‐positive mid‐proximal dendritic inhibitory interneurons. Only a fraction of low CB1‐expressing cells is GABAergic. In the hippocampus, amygdala and entorhinal cortex area, CB1 mRNA is present at low but significant levels in many non‐GABAergic cells that can be considered as projecting principal neurons. Thus, a complex mechanism appears to underlie the modulatory effects of cannabinoids. They might act on principal glutamatergic circuits as well as modulate local GABAergic inhibitory circuits. CB1 is very highly coexpressed with CCK. It is known that cannabinoids and CCK often have opposite effects on behaviour and physiology. Therefore, we suggest that a putative cross‐talk between cannabinoids and CCK might exist and will be relevant to better understanding of physiology and pharmacology of the cannabinoid system.
European Journal of Neuroscience – Wiley
Published: Dec 1, 1999
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.